Clinical Trial Update: Efficacy of Intravenous Melatonin on Mortality in Adult Patients Admitted to the Intensive Care Unit With COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intravenous melatonin for mortality outcomes in adults with COVID-19 in the ICU; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Pharmamel S.L. | Conditions: COVID-19, SARS-CoV 2 | Phase 2 | Status: COMPLETED